These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system. Spina MB; Squinto SP; Miller J; Lindsay RM; Hyman C J Neurochem; 1992 Jul; 59(1):99-106. PubMed ID: 1613515 [TBL] [Abstract][Full Text] [Related]
4. Glial cell line-derived neurotrophic factor protects dopaminergic neurons from 6-hydroxydopamine toxicity in vitro. Eggert K; Schlegel J; Oertel W; Würz C; Krieg JC; Vedder H Neurosci Lett; 1999 Jul; 269(3):178-82. PubMed ID: 10454161 [TBL] [Abstract][Full Text] [Related]
5. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs. Seroogy KB; Lundgren KH; Tran TM; Guthrie KM; Isackson PJ; Gall CM J Comp Neurol; 1994 Apr; 342(3):321-34. PubMed ID: 7912699 [TBL] [Abstract][Full Text] [Related]
6. Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease. Levivier M; Przedborski S; Bencsics C; Kang UJ J Neurosci; 1995 Dec; 15(12):7810-20. PubMed ID: 8613721 [TBL] [Abstract][Full Text] [Related]
8. Astrocytes promote or impair the survival and function of embryonic ventral mesencephalon co-grafts: effects of astrocyte age and expression of recombinant brain-derived neurotrophic factor. Krobert K; Lopez-Colberg I; Cunningham LA Exp Neurol; 1997 Jun; 145(2 Pt 1):511-23. PubMed ID: 9217087 [TBL] [Abstract][Full Text] [Related]
9. Dental pulp cells provide neurotrophic support for dopaminergic neurons and differentiate into neurons in vitro; implications for tissue engineering and repair in the nervous system. Nosrat IV; Smith CA; Mullally P; Olson L; Nosrat CA Eur J Neurosci; 2004 May; 19(9):2388-98. PubMed ID: 15128393 [TBL] [Abstract][Full Text] [Related]
10. Protective effect of platelet-derived growth factor against 6-hydroxydopamine-induced lesion of rat dopaminergic neurons in culture. Pietz K; Odin P; Funa K; Lindvall O Neurosci Lett; 1996 Feb; 204(1-2):101-4. PubMed ID: 8929988 [TBL] [Abstract][Full Text] [Related]
11. Effects of donor age and brain-derived neurotrophic factor on the survival of dopaminergic neurons and axonal growth in postnatal rat nigrostriatal cocultures. Ostergaard K; Jones SA; Hyman C; Zimmer J Exp Neurol; 1996 Dec; 142(2):340-50. PubMed ID: 8934565 [TBL] [Abstract][Full Text] [Related]
12. Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo. Lindholm P; Voutilainen MH; Laurén J; Peränen J; Leppänen VM; Andressoo JO; Lindahl M; Janhunen S; Kalkkinen N; Timmusk T; Tuominen RK; Saarma M Nature; 2007 Jul; 448(7149):73-7. PubMed ID: 17611540 [TBL] [Abstract][Full Text] [Related]
13. Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain. Knüsel B; Beck KD; Winslow JW; Rosenthal A; Burton LE; Widmer HR; Nikolics K; Hefti F J Neurosci; 1992 Nov; 12(11):4391-402. PubMed ID: 1432101 [TBL] [Abstract][Full Text] [Related]
14. Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration. Natsume A; Mata M; Goss J; Huang S; Wolfe D; Oligino T; Glorioso J; Fink DJ Exp Neurol; 2001 Jun; 169(2):231-8. PubMed ID: 11358438 [TBL] [Abstract][Full Text] [Related]
15. Differential effects of glial cell line-derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons. Akerud P; Alberch J; Eketjäll S; Wagner J; Arenas E J Neurochem; 1999 Jul; 73(1):70-8. PubMed ID: 10386956 [TBL] [Abstract][Full Text] [Related]
16. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Hyman C; Hofer M; Barde YA; Juhasz M; Yancopoulos GD; Squinto SP; Lindsay RM Nature; 1991 Mar; 350(6315):230-2. PubMed ID: 2005978 [TBL] [Abstract][Full Text] [Related]
17. Cytoprotective effects of growth factors: BDNF more potent than GDNF in an organotypic culture model of Parkinson's disease. Stahl K; Mylonakou MN; Skare Ø; Amiry-Moghaddam M; Torp R Brain Res; 2011 Mar; 1378():105-18. PubMed ID: 21236244 [TBL] [Abstract][Full Text] [Related]
18. The response of human and rat fetal ventral mesencephalon in culture to the brain-derived neurotrophic factor treatment. Zhou J; Bradford HF; Stern GM Brain Res; 1994 Sep; 656(1):147-56. PubMed ID: 7804829 [TBL] [Abstract][Full Text] [Related]
19. Protein tyrosine phosphatase inhibition reduces degeneration of dopaminergic substantia nigra neurons and projections in 6-OHDA treated adult rats. Yang P; Dankowski A; Hagg T Eur J Neurosci; 2007 Mar; 25(5):1332-40. PubMed ID: 17425559 [TBL] [Abstract][Full Text] [Related]
20. Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor. Ding YM; Jaumotte JD; Signore AP; Zigmond MJ J Neurochem; 2004 May; 89(3):776-87. PubMed ID: 15086533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]